AB
Adaptive Biotechnologies Corp
🇩🇪XFRA.1HMGermanyHealthcare
€21.10EURup +0.50 (+2.43%)OpenEnd of day5:11 PM
Price€21.10+0.50 (+2.43%)
Profile
- Healthcare
- Diagnostics & Research
- Germany
Identity
- Exchange
- Frankfurt Stock Exchange . XFRA
- Type
- Stock
- ISIN
- US00650F1093
- CUSIP
- Not reported
Company
- Employees
- 624
- Headquarters
- Seattle, United States
- CEO
- Mr. Chad M. Robins M.B.A.
Market
- Shares outstanding
- 152.7M
- Market cap
- €3.22B
Highlights
No high and low reported for today's session.
- Market cap
- €3.22B
- EPS LTM
- -$0.40
- P/E LTM
- -51.67
- Div yield
- Not reported
Fundamentals (LTM)
- Revenue
- $308.08M+50.13%up year on year
- Net income
- -$63.85M+47.33%up year on year
- Gross margin
- 75.44%+14.23%up year on year
- Free cash flow
- -$24.03M+70.98%up year on year
Other listings
These are the venues Finzer covers, not every venue that exists.
Business summary
No company summary reported yet.